SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 222 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
6324ACHN—yesterday and today—cumulative 2-day gain of 170%: siliconinvestor.comDewDiligence_on_SI-6/10/2014
6323HALO +15.6% (Halozyme Therapeutics to resume PEGPH20 clinical program in pancreatnsaf-6/5/2014
6322RTRX 25%nigel bates-5/30/2014
6321NPSP 16%- <i>LONDON, May 30 (Reuters) - London-listed drugmaker Shire is nigel bates-5/30/2014
6320PTCT, which had fireworked on the day of the positive CHMP opinion but gave a lotuck-5/28/2014
6319TGTX has a lot of +15% and -15% days when there is seemingly no news.DewDiligence_on_SI-5/27/2014
6318Two of the past three trading days... TGTX...... big bounce off bottom in thrscaram(o)uche-5/27/2014
6317TG Therapeutics (TGTX) 16%. Some news from Thursday, but you'd think the retuck-5/27/2014
6316DYAX 20% or so.nigel bates-5/27/2014
6315Innate (IPHYF), which had come back some with other momo bios, up 20%. Don'tuck-5/27/2014
6314RNA +33% - Theflyonthewall: Prosensa mentioned positively after PTC news by TheStnsaf-5/23/2014
6313ITMN +16%, closed +13%, after reporting data on pirfenidonetnsaf-5/19/2014
6312CLVS <i>Clovis data encouraging compared to AstraZeneca, says Mizuho Mizutom pope-5/15/2014
6311Over 27 % for BLUE also.sjemmeri-5/14/2014
6310CLDX up 25% on BMY clinical trial collaboration. Bit of an over-reaction ? Thenigel bates-5/14/2014
6309Celldex (CLDX) up 15% 0n no news. Looks like an oversold bounce. Cheers, Tucktuck-5/9/2014
6308ADHXF or AHX.to just had a nearly 100% up week without news. The volume is stilwookie94-5/4/2014
6307MACK +60% Merrimack Pharma announces MM-398 achieves primary endpoint of overalltnsaf-5/1/2014
6306AGEN moved up on new deal with Merck. Agenus announces collaboration and licenRon-4/28/2014
6305AGN +15% on buyout offer from VRX and Pershing: siliconinvestor.comDewDiligence_on_SI-4/22/2014
6304Xenoport (XNPT) up 18% after hitting new annual low last week. Apparently due Lance Bredvold-4/22/2014
6303Epizyme (EPZM), having cratered since BJ's post, bounces 16% on news of a mituck-4/22/2014
6302SRPT +50% Sarepta Therapeutics Inc. said Monday that it would submit a new drug tnsaf-4/21/2014
6301Given that the injectable insulin products are so much more user friendly than DewDiligence_on_SI-4/2/2014
6300MannKind (MNKD) up 76% on FDA AC reco for approval of its inhaled insulin. Givetuck-4/2/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News